Metis Precision Medicine
Business Description Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action. Currently seeking investors, biotech, or pharmaceutical companies interested in acquiring the relevant platform technology on a global basis.
Tags Biotechnology, Health Care, Pharmaceutical
Website https://www.metisprecisionmedicine.org/
Articles about Metis Precision Medicine:
💡 You're a corporate or investor and looking for startups that are innovating in the same market as
Metis Precision Medicine? We're happy to assist you with our
Startup Sourcing service.
